Kelly Shi
Stock Analyst at Jefferies
(1.97)
# 2,974
Out of 4,868 analysts
30
Total ratings
39.29%
Success rate
-5.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Initiates: Buy | $105 | $102.68 | +2.26% | 1 | May 13, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $20.56 | +114.01% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $4.93 | +204.26% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $27.70 | +87.73% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.72 | +196.92% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $12.46 | +52.49% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $176.47 | +11.07% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $1.58 | +1,229.11% | 1 | Aug 13, 2024 | |
| SNDX Syndax Pharmaceuticals | Initiates: Buy | $37 | $9.48 | +290.30% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $0.66 | +808.95% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $46 | $50.20 | -8.37% | 3 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $68.46 | +18.32% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $25.22 | +38.78% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.79 | +1,911.17% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $43.50 | -63.22% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $45.87 | -12.80% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.63 | +331.97% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.87 | +178.75% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.67 | +3,929.85% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $14.83 | +250.64% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $1.03 | +2,521.36% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.91 | +1,627.75% | 1 | Mar 8, 2021 |
Insmed
May 13, 2025
Initiates: Buy
Price Target: $105
Current: $102.68
Upside: +2.26%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $20.56
Upside: +114.01%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $4.93
Upside: +204.26%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $27.70
Upside: +87.73%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.72
Upside: +196.92%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $12.46
Upside: +52.49%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $176.47
Upside: +11.07%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $1.58
Upside: +1,229.11%
Syndax Pharmaceuticals
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $9.48
Upside: +290.30%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $0.66
Upside: +808.95%
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $50.20
Upside: -8.37%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $68.46
Upside: +18.32%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $25.22
Upside: +38.78%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $1.79
Upside: +1,911.17%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $43.50
Upside: -63.22%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $45.87
Upside: -12.80%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $4.63
Upside: +331.97%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.87
Upside: +178.75%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.67
Upside: +3,929.85%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $14.83
Upside: +250.64%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $1.03
Upside: +2,521.36%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.91
Upside: +1,627.75%